APA
Li W., Gupta S. K., Han W., Kundson R. A., Nelson S., Knutson D., Greipp P. T., Elsawa S. F., Sotomayor E. M. & Gupta M. (20200731). Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors. : Journal of hematology & oncology.
Chicago
Li Weiping, Gupta Shiv K, Han Weiguo, Kundson Ryan A, Nelson Sara, Knutson Darlene, Greipp Patricia T, Elsawa Sherine F, Sotomayor Eduardo M and Gupta Mamta. 20200731. Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors. : Journal of hematology & oncology.
Harvard
Li W., Gupta S. K., Han W., Kundson R. A., Nelson S., Knutson D., Greipp P. T., Elsawa S. F., Sotomayor E. M. and Gupta M. (20200731). Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors. : Journal of hematology & oncology.
MLA
Li Weiping, Gupta Shiv K, Han Weiguo, Kundson Ryan A, Nelson Sara, Knutson Darlene, Greipp Patricia T, Elsawa Sherine F, Sotomayor Eduardo M and Gupta Mamta. Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors. : Journal of hematology & oncology. 20200731.